Proteostasis Therapeutics, Inc. Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Proteostasis Therapeutics (PTI) IPO Opens Flat
February 11, 2016 10:27 AM ESTToday's IPO for Proteostasis Therapeutics (NYSE: PTI) opened for trading at $8 after pricing 6,250,000 shares of common stock at a public offering price of $8.00 per share, before underwriting discounts and commissions. The company had planned to offer 3,850,000 shares at $12-$14.
Leerink Partners and RBC... More
Proteostasis Therapeutics (PTI) Prices Upsized IPO at $8, Well Below Plan
February 11, 2016 8:26 AM ESTProteostasis Therapeutics, Inc. (NYSE: PTI) announced the pricing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $8.00 per share, before underwriting discounts and commissions. The company had planned to offer 3,850,000 shares at $12-$14. Shares are expected to... More
